ERT

DigiCert, DataMotion partner for secure health information exchange

Thursday, June 13, 2013 11:30 AM

DigiCert, a high-assurance digital certificate provider, and DataMotion, a health information service provider (HISP) with 14 years of experience in secure data delivery services, have partnered to expand common dual-mode certification for commercial and federal use for the healthcare industry. The partnership plans to improve patient care by making it much simpler for federal and non-federal organizations to engage in the secure electronic exchange of healthcare information.

More... »

Certara, Veristat partner for combined service offerings

Tuesday, May 14, 2013 01:37 PM

Certara, a provider of software and scientific consulting services from drug discovery through clinical development, and Veristat, a full-service CRO, have formed an alliance to offer combined services to their clients.

More... »

Concert Pharmaceuticals, Celgene to develop deuterium-modified compounds

Tuesday, May 7, 2013 08:00 AM

Concert Pharmaceuticals, a clinical stage biotechnology company, has entered into a strategic collaboration with Celgene, a Summit, N.J.-based integrated global biopharmaceutical company, directed towards deuterium-modified compounds targeting cancer and inflammation. The collaboration will initially focus on one program, but has the potential to encompass multiple targets.

More... »

Calvert Laboratories inks deal with Particle Sciences on early-stage development

Monday, March 18, 2013 11:53 AM

Calvert Laboratories and Particle Sciences, two CROs in the fields of preclinical toxicology and drug product formulation, have joined forces to offer a streamlined solution to expedite preclinical drug development activities. 

More... »

Parexel CEO Rickenbach to receive MassBio’s Henri Termeer Innovative Leadership Award

Monday, March 11, 2013 02:35 PM

Josef von Rickenbach, chairman and CEO of Parexel International, a global bio/pharmaceutical services organization, will be honored for his commitment and contributions to the biotechnology industry, by the Massachusetts Biotechnology Council (MassBio), a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry.

More... »

Agility Clinical partners with PSR Orphan Experts

Wednesday, March 6, 2013 02:22 PM

Carlsbad, Calif.-based Agility Clinical, a specialty CRO, has partnered with PSR Orphan Experts, a specialty consulting and clinical research company based in the Netherlands., a move that will provide clients with access to orphan drug development expertise and services on both sides of the Atlantic. The term “orphan drug” refers to pharmaceutical products developed specifically to treat rare diseases that affect fewer than 200,000 Americans or less than one in 2,000 Europeans.

More... »

Jazz, Concert partner to develop deuterium-modified sodium oxybate

Wednesday, February 27, 2013 11:54 AM

Jazz Pharmaceuticals, an Irish specialty biopharmaceutical company focused on unmet medical needs, and Concert Pharmaceuticals, a Lexington, Mass.-based clinical stage biotechnology company, have signed an exclusive license agreement that provides Jazz Pharmaceuticals worldwide rights to develop and commercialize Concert's deuterium-modified sodium oxybate (D-SXB) compounds, including C-10323.   

More... »

RWJF awards $1.9M grant to PatientsLikeMe

Monday, February 25, 2013 11:26 AM

PatientsLikeMe, a patient network that improves lives and a real-time research platform that advances medicine, has been awarded a $1.9 million grant from the Robert Wood Johnson Foundation (RWJF) to create the world's first open-participation research platform for the development of patient-centered health outcome measures.

More... »

Synteract appoints Kelson as CFO, Doren as vice president of biometrics

Wednesday, January 30, 2013 03:18 PM

Synteract, a full service CRO based in Carlsbad, Calif., has hired new executives to support customers on a global scale. Keith Kelson will serve as chief financial officer and member of its executive council, and Phil Doren has been appointed vice president of biometrics.

More... »

ERT expands corporate presence in Japan

Wednesday, January 16, 2013 09:26 AM

ERT, a global technology-driven provider of health outcomes research services, has completed registration for Kabushiki Kaisha (KK) in Japan and has formed a fully-owned subsidiary, ERT Asia Group.

More... »